PWPS
TXG icon

Pinnacle Wealth Planning Services’s 10x Genomics TXG Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$154K Sell
4,011
-45
-1% -$1.18K 0.01% 648
2026
Q1 		$86.1K Buy
4,056
+114
+3% +$2.28K 0.01% 875
2025
Q4 		$64.3K Buy
+3,942
New +$59.5K 0.01% 1034
2021
Q1 		– Sell
-13
Closed -$2K – 1829
2020
Q4 		$2K Buy
+13
New +$1.89K ﹤0.01% 1992

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pinnacle Wealth Planning Services's TXG Position: Q2 2026 in Review

Pinnacle Wealth Planning Services reduced its 10x Genomics (TXG) stake by 1.1% in Q2 2026, selling an estimated $1.18K and leaving 4,011 shares worth $154K. The position accounts for 0.01% of the portfolio, ranked #648.

Pinnacle Wealth Planning Services first reported a position in TXG in Q4 2020 and has held it in 4 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Pinnacle Wealth Planning Services held 4,011 shares of 10x Genomics worth $154K as of Q2 2026.
  • Pinnacle Wealth Planning Services sold 45 10x Genomics shares in Q2 2026, an estimated $1.18K.
  • 10x Genomics made up 0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #648 holding.
  • Pinnacle Wealth Planning Services first reported a position in 10x Genomics in Q4 2020 and has held it in 4 quarters since.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.